Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 12/11/15

Nita L. Seibel, MD

Nita L. Seibel, MD

Head — Pediatric Solid Tumors

Dr. Nita L. Seibel, a board certified pediatric hematologist-oncologist is the head of the Pediatric Solid Tumor Therapeutics in the Clinical Investigations Branch of the Cancer Therapy and Evaluation Program of the National Cancer Institute. Dr. Seibel received her medical degree from Ohio State University College of Medicine and Public Health and completed her residency in pediatrics at Ohio State University/Nationwide Children’s Hospital. She joined the faculty of George Washington University School of Medicine and Public Health and Children’s National Medical Center in pediatric hematology/oncology after completing her fellowship on the Pediatric Oncology Branch of the National Cancer Institute. During her 20 years as an attending physician at Children’s National Medical Center, she held numerous positions which included Solid Tumor Director, Hematology/Oncology Fellowship Training Program Director, Outreach Services Director for the Department of Hematology/Oncology, and Principal Investigator for the Children’s Oncology Group as well as Professor of Pediatrics at George Washington University School of Medicine. In addition to her role in the development of the extramural Pediatric Solid Tumor Program which includes co-chairing the NCI Pediatric MATCH study, she is also the scientific liaison for the Childhood Cancer Survivor Study and NCI Pediatric Central Institutional Review Board, co-chairs the Trans-NCI Adolescent and Young Adult Working Group and a member of the Editorial Board for the NCI Physician Data Query (PDQ) Pediatric Board. Dr. Seibel has published over 100 articles, 80 abstracts, and numerous book chapters

Contact Information:
National Cancer Institute
9609 Medical Center Dr., MSC 9739
For USPS: Bethesda, MD 20892-9739
For Express and Courier: Rockville, MD 20850
Phone: 240-276-6560
Fax: 240-276-7892
E-mail: seibelnl@mail.nih.gov

About the Branch Chief

Meg Mooney, MD Meg Mooney, MD, MBA, became the Acting Associate Director of CTEP in December 2018, with oversight and coordination responsibilities for the programmatic, financial, and administrative functions for the entire CTEP program, which covers a broad, multidisciplinary, clinical research effort to coordinate nationwide phase 1-3 clinical trials programs testing new treatment approaches for cancer. She is also the Chief of the Clinical Investigations Branch. More…